Supporting Wound Care Evaluation: Biological Evaluation, Nanomaterials and Manufacturing Considerations
Speakers:
- Anja Friedrich - CEO Eurofins Medical Device Testing France
- Dr. Helge Gehrke- Senior Scientific Director in vitro Toxicology and Alternative Methods
- Aude Bévillard - Biocompatibility and Toxicology Consultant
Date: 15th October 2026
Time: 15:00 - 16:00 CET
Webinar Format:
- 30-minute expert presentation
- 30-minute panel discussion and live Q&A session
Join Eurofins for an insightful webinar on the evolving landscape of wound management products.
The wound care sector continues to expand with a growing variety of innovative products, including hemostatic agents, wound closure devices, advanced adhesive-based materials, and other novel technologies designed to improve patient outcomes. As these products become increasingly complex, manufacturers face new challenges in demonstrating safety, performance, and regulatory compliance.
📌 In this webinar, you will learn:
- How the diversity of wound care products influences biological evaluation strategies
- The impact of ISO 10993-1 updates and product clusterisation
- Best practices for sample preparation, chemical characterisation, and hemocompatibility testing
- Key considerations for nanoparticle-containing wound care products
- Approaches to cleaning validation and packaging compliance
- Practical strategies for navigating biological safety requirements
👤 Who Should Join?
- Regulatory Affairs Professionals
- Medical Device Manufacturers & Product Development Teams
- Quality, Validation & Biological Safety Experts
- R&D Scientists and Material Experts
In Summary:
This webinar will explore the unique considerations associated with the biological evaluation of wound management products and discuss how recent updates to ISO 10993-1 impact testing strategies and product categorisation approaches. Our experts will explain the importance of appropriate product clusterisation and risk-based biological evaluation pathways for different wound care applications.
The session will also cover key testing considerations, including sample preparation, chemical characterization, and hemocompatibility assessment, alongside nanoparticle applications and cleaning validation and packaging considerations. The presentation concludes with a dedicated expert panel discussion and live Q&A session.